REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma Calendula Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Pharma Calendula Egeszsegugyi Szolgaltato Bt. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Pharma Calendula Bt. is based in Hungary. The head office is in Dunakeszi. It operates in the Pharmacies and Drug Stores sector. It was incorporated on July 15, 1996. Pharma Calendula Bt. currently employs 5 (2023) people. From the latest financial highlights, Pharma Calendula Bt. reported a net sales revenue increase of 11.11% in 2022. During that time, Pharma Calendula Bt.’s total assets grew by 28.29%. In 2022, Pharma Calendula Bt.’s net profit margin increased by 1.08%.

Headquarters
Fo ut 130.
Dunakeszi; Pest; Postal Code: 2120

Contact Details: Purchase the Pharma Calendula Bt. report to view the information.

Website: http://www.calanduladunakeszi.novodata.hu

Basic Information
Total Employees:
Purchase the Pharma Calendula Bt. report to view the information.
Outstanding Shares:
Purchase the Pharma Calendula Bt. report to view the information.
Registered Capital:
Purchase the Pharma Calendula Bt. report to view the information.
Financial Auditors:
Purchase the Pharma Calendula Bt. report to view the information.
Incorporation Date:
July 15, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pharma Calendula Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
11.11%
Total operating revenue
10.98%
Operating profit (EBIT)
32.28%
EBITDA
29.78%
Net Profit (Loss) for the Period
32.27%
Total assets
28.29%
Total equity
31.75%
Operating Profit Margin (ROS)
1.08%
Net Profit Margin
1.08%
Return on Equity (ROE)
0.1%
Quick Ratio
0.14%
Cash Ratio
0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?